Survey of drug-related problems identified by community pharmacies

Annals of Pharmacotherapy

Volumn 41, Issue 11, 2007, Pages 1825-1832

  Hämmerlein, Andrea ^a   Griese, Nina ^a   Schulz, Martin ^a,b,c  

^a Center for Drug Information and Pharmacy Practice   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c ABDA Federal Union of German Associations of Pharmacists   (Germany)

Author keywords

Ambulatory care; Community pharmacy; Drug safety; Drug related problems; Medication error

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ASCORBIC ACID; ATORVASTATIN; BUDESONIDE PLUS FORMOTEROL; CARVEDILOL; CHOLINE SALICYLATE; DICLOFENAC; ENALAPRIL; IBUPROFEN; INSULIN; LAXATIVE; LISINOPRIL; LORATADINE; METFORMIN; MUNDISAL; NON PRESCRIPTION DRUG; NOSE SPRAY; PHENPROCOUMON; SIOFOR; TETRYZOLINE; UNCLASSIFIED DRUG; VALDECOXIB; XYLOMETAZOLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COMMUNITY CARE; DATA BASE; DRUG INTERACTION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICATION ERROR; NEWBORN; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RESPONSIBILITY; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; DRUG INTERACTIONS; DRUGS, NON-PRESCRIPTION; FEMALE; GERMANY; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; PHARMACISTS; PRESCRIPTIONS, DRUG; PROFESSIONAL ROLE;

EID: 35748935857     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K207     Document Type: Article

References (24)

1. Kaiser Family Foundation. Prescription drug trend fact sheet (May 2007 update). www.kff.org/rxdrugs/upload/3057_06.pdf (accessed 2007 Jun 15).
2. Schwabe U, Paffrath D. Arzneiverordnungs-Report 2005. Berlin: Springer.
3. Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health 1997;87:1626-9.
4. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85.
5. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9.
6. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155:1949-56.
7. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997; 54:554-8.
8. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
9. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120-7.
10. Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 2006;40:729-35. Epub 28 Mar 2006. DOI 10.1345/aph.1G458
11. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2003, Oslo.
12. Buurma H, De Smet PA, Egberts AC. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. Drug Saf 2006;29:723-32.
13. Haugbolle LS, Sorensen EW. Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma - interviewing patients at home. Pharm World Sci 2006;28:239-47.
14. Leemans L, Veroeveren L, Bulens J, et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci 2003;25:65-9.
15. Samoy LJ, Zed PJ, Wilbur K, Balen RM, bu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy 2006;26:1578-86.
16. Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001;35:1343-9. DOI 10.1345/aph.1A065
17. Westerlund T, Almarsdotfir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999;21:245-50.
18. Westerlund T, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999;7:40-50.
19. Diener F. [Economic report on community pharmacies in Germany - consolidation of the industry sector] German. Pharm Ztg 2006;151:1658-69.
20. Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 2003;26:1065-74.
21. Francis SA, Barnett N, Denham M. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly? Drugs Aging 2005;22:361-70.
22. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002;22:915-23.
23. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2007;16:641-51.
24. ABDATA Pharma-Daten-Service. ABDA-Datenbank. Werbe- und Vertriebsgesellschaft Deutscher Apotheker mbH, Eschborn, Germany, 2005.